P. Rhomberg

发表

Isavuconazole, micafungin, and 8 comparator antifungal agents' susceptibility profiles for common and uncommon opportunistic fungi collected in 2013: temporal analysis of antifungal drug resistance using CLSI species-specific clinical breakpoints and proposed epidemiological cutoff values.

M. Castanheira, P. Rhomberg, M. Pfaller, 2015, Diagnostic microbiology and infectious disease.

Report from the 2005 MYSTIC Surveillance Program (USA): Influence of Antimicrobial Resistant Clusters on Overall Prevalence Patterns

P. Rhomberg, R. Jones, L. Deshpande, 2006 .

Group B streptococci causing neonatal bloodstream infection: antimicrobial susceptibility and serotyping results from SENTRY centers in the Western Hemisphere.

Ronald N. Jones, P. Rhomberg, M. Pfaller, 2000, American journal of obstetrics and gynecology.

Comparative evaluation of etest for susceptibility testing Neisseria meningitidis with eight antimicrobial agents. An investigation using U.S. Food and Drug Administration regulatory criteria.

R. Jones, S. Marshall, P. Rhomberg, 1997, Diagnostic microbiology and infectious disease.

Antifungal activity of a new triazole, D0870, compared with four other antifungal agents tested against clinical isolates of Candida and Torulopsis glabrata.

M. Pfaller, B. Buschelman, M. Bale, 1994, Diagnostic microbiology and infectious disease.

Neisseria meningitidis with decreased susceptibility to penicillin: report from the SENTRY antimicrobial surveillance program, North America, 1998-99.

S. Richter, P. Rhomberg, M. Pfaller, 2001, Diagnostic microbiology and infectious disease.

In Vitro Activity of β-Lactam Antimicrobial Agents in Combination with Aztreonam Tested Against Metallob-β-Lactamase-Producing Pseudomonas aeruginosa and Acinetobacter baumannii

R. Jones, H. Sader, P. Rhomberg, 2005, Journal of chemotherapy.

Activities of Manogepix and Comparators against 1,435 Recent Fungal Isolates Collected during an International Surveillance Program (2020)

M. Castanheira, M. Huband, M. Pfaller, 2022, Antimicrobial agents and chemotherapy.

Telavancin Activity Against Gram-Positive Bacteria Isolated from Patients with Skin and Skin-Structure Infections

M. Pfaller, R. Jones, H. Sader, 2010, Journal of chemotherapy.

Activity of Isavuconazole and Comparator Antifungals Tested against Contemporary (2012) Fungal Clinical Isolates Collected Worldwide

M. Castanheira, S. Messer, M. Pfaller, 2013 .

Activity of a Novel Echinocandin Biafungin (CD101) Tested against Most Common Candida and Aspergillus Species, Including Echinocandin- and Azole-resistant Strains

M. Castanheira, S. Messer, M. Pfaller, 2014 .

ANTIMICROBIAL ACTIVITY OF A NOVEL POLYMYXIN ANALOG (CB-182,804) TESTED AGAINST CLINICAL STRAINS OF GRAM-NEGATIVE BACILLI, INCLUDING COLISTIN-RESISTANT ORGANISMS

R. Jones, H. Sader, P. Rhomberg, 2010 .

Gepotidacin (GSK2140944) In Vitro Activity against Gram-Positive and Gram-Negative Bacteria

D. Farrell, R. Flamm, H. Sader, 2017, Antimicrobial Agents and Chemotherapy.

Outbreak of severe Pseudomonas aeruginosa infections caused by a contaminated drain in a whirlpool bathtub.

L A Herwaldt, P. Rhomberg, M. Pfaller, 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Comparative Antimicrobial Potency of Meropenem Tested Against Gram-Negative Bacilli: Report from the MYSTIC Surveillance Program in the United States (2004)

P. Rhomberg, R. Jones, T. Fritsche, 2005, Journal of chemotherapy.

Pre-clinical Evaluation of a Carbapenem/ß-Lactamase Inhibitor Combination (RPX2003/RPX7009) Tested Against Serine-carbapenemase-producing Pathogens

M. Castanheira, P. Rhomberg, H. Becker, 2012 .

Comparison of identification systems for Staphylococcus epidermidis and other coagulase-negative Staphylococcus species.

T. Perl, M. Pfaller, F. Koontz, 1994, Diagnostic microbiology and infectious disease.

In Vitro Spectrum of Pexiganan Against Pathogens from Diabetic Foot Infections and with Selected Resistance Mechanisms

H. Sader, P. Rhomberg, D. Farrell, 2014 .

Antimicrobial Activity of TD-1607 Tested against Contemporary (2010-2012) Methicillin-Resistant Staphylococcus aureus (MRSA) Strains

H. Sader, P. Rhomberg, D. Farrell, 2014 .

In Vitro Activity of Delafloxacin against Contemporary Bacterial Pathogens from the United States and Europe, 2014

P. Rhomberg, M. Pfaller, H. Sader, 2017, Antimicrobial Agents and Chemotherapy.

Activity of JNJ-Q2, a New Fluoroquinolone, Tested Against Contemporary (2010) European Pathogens Isolated from Patients with Acute Bacterial Skin and Skin-Structure Infections

P. Rhomberg, D. Farrell, R. Jones, 2011 .

In Vitro Activity of Gepotidacin (GSK2140944) against Neisseria gonorrhoeae

P. Rhomberg, D. Farrell, H. Sader, 2017, Antimicrobial Agents and Chemotherapy.